Related Experiment Video
Updated: Mar 19, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Treatment of Disseminated Intravascular Coagulation
Insights
Disseminated intravascular coagulation (DIC) lacks a diagnostic gold standard, relying on low-quality evidence. Treatment focuses on underlying conditions and supportive care, with no definitive evidence-based guidelines.
Area of Science:
- Hematology
- Internal Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a critical condition involving systemic coagulation activation and microvascular dysfunction.
- Current diagnostic and treatment protocols for DIC are based on limited evidence, posing challenges in clinical practice.
Purpose of the Study:
- To define Disseminated intravascular coagulation (DIC) based on the International Society of Thrombosis and Haemostasis (ISTH) criteria.
- To review the diagnostic and therapeutic approaches for DIC, highlighting the limitations in evidence quality.
Main Methods:
- The article defines DIC and its diagnostic criteria according to the ISTH.
- It discusses the diagnostic tests and repeated measurements commonly employed for DIC.
- Evidence quality for both diagnosis and treatment of DIC is critically evaluated.
Main Results:
- There is no universally accepted gold standard for diagnosing DIC.
- Diagnostic criteria rely on the ISTH guidelines, often requiring multiple tests and serial assessments.
- High-quality evidence for DIC treatment is lacking; management primarily involves addressing the underlying cause and supportive transfusions.
Conclusions:
- Diagnosis and management of DIC are challenging due to the absence of a gold standard and reliance on low-quality evidence.
- Effective DIC management hinges on prompt identification of the underlying etiology and appropriate supportive interventions.
- Further research is needed to establish robust diagnostic and therapeutic guidelines for DIC.
Abstract:
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic activation of blood coagulation, generation of thrombin, and leading to disturbance of the microvasculature. In this article, definition and diagnostic criteria of DIC depend on the International Society of Thrombosis and Haemostasis (ISTH). There is no gold standard for diagnosis of DIC, only low quality evidence is used in general practice. Many diagnostic tests and repeated measurement are required. For the treatment of DIC, there is no good quality evidence. The most important treatment for DIC is the specific treatment of the conditions associated DIC. Platelets and/or plasma transfusion may be also necessary if indicated. Nevertheless, there is no gold standard for diagnosis and treatment of DIC, we use only low quality evidence in general practice.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation

